Hydroxychloroquine May be Beneficial for Preeclampsia

NCT06020378 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 462

Last updated 2025-04-24

No results posted yet for this study

Summary

The purpose of this research is to investigate the impact of hydroxychloroquine on the incidence of hypertensive pregnancy disorders in women with a history of recurrent spontaneous abortion (RSA).

Conditions

  • Pre-Eclampsia

Interventions

DRUG

Hydroxychloroquine

Hydroxychloroquine was administered during pregnancy

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-07-01
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06020378 on ClinicalTrials.gov